Search Results - "Phillips, Gregory S"

Treatment Outcomes of Immune-Related Cutaneous Adverse Events by Phillips, Gregory S, Wu, Jennifer, Hellmann, Matthew D, Postow, Michael A, Rizvi, Naiyer A, Freites-Martinez, Azael, Chan, Donald, Dusza, Stephen, Motzer, Robert J, Rosenberg, Jonathan E, Callahan, Margaret K, Chapman, Paul B, Geskin, Larisa, Lopez, Adriana T, Reed, Vanessa A, Fabbrocini, Gabriella, Annunziata, Maria Carmela, Kukoyi, Oluwaseun, Pabani, Aliyah, Yang, Chih-Hsun, Chung, Wen-Hung, Markova, Alina, Lacouture, Mario E

“…The aim of the current study was to report the efficacy of topical and systemic treatments for immune-related cutaneous adverse events (ircAEs) attributed to…”
Get full text

Multisystem ALK-Positive Histiocytosis With DCTN1::ALK Fusion in an Adult, Responsive to Alectinib: Case Report and Literature Review by Phillips, Gregory S, Knapp, Maxwell, Olsen, Keith C, Martin, William, Hayes-Lattin, Brandon, Chung, Jina

“…Anaplastic lymphoma kinase (ALK)-positive histiocytosis has emerged as a clinically relevant diagnosis featuring a wide span of clinical presentations, which…”
Get full text

Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients by Phillips, Gregory S., Freites-Martinez, Azael, Hsu, Meier, Skripnik Lucas, Anna, Barrios, Dulce M., Ciccolini, Kathryn, Marchetti, Michael A., Deng, Liang, Myskowski, Patricia L., Lee, Erica H., Markova, Alina, Lacouture, Mario E.

“…Dermatologic conditions cause morbidity and mortality among hospitalized cancer patients. An improved understanding is critical for implementing clinical and…”
Get full text

Immune checkpoint inhibitor–related dermatologic adverse events by Geisler, Amaris N., Phillips, Gregory S., Barrios, Dulce M., Wu, Jennifer, Leung, Donald Y.M., Moy, Andrea P., Kern, Jeffrey A., Lacouture, Mario E.

“…Immune checkpoint inhibitors have emerged as a pillar in the management of advanced malignancies. However, nonspecific immune activation may lead to…”
Get full text

Immune checkpoint inhibitors to treat cutaneous malignancies by Barrios, Dulce M., Do, Mytrang H., Phillips, Gregory S., Postow, Michael A., Akaike, Tomoko, Nghiem, Paul, Lacouture, Mario E.

“…As the incidence of cutaneous malignancies continues to rise and their treatment with immunotherapy expands, dermatologists and their patients are more likely…”
Get full text

Clinical Characterization of Immunotherapy-Related Pruritus Among Patients Seen in 2 Oncodermatology Clinics by Phillips, Gregory S, Freites-Martinez, Azael, Wu, Jennifer, Chan, Donald, Fabbrocini, Gabriella, Hellmann, Matthew D, Lacouture, Mario E

Get more information

Leishmaniasis masquerading as pyoderma gangrenosum in a non‐endemic area: A case report by Becker, Sarah L., Phillips, Gregory S., Keller, Jesse, Sheth, Radhika, Egge, Stephanie, Koon, Stephanie Mengden, Ortega‐Loayza, Alex G.

“…Abstract Pyoderma gangrenosum (PG) can be difficult to diagnose, leading to diagnostic delay which affects patient outcomes and increases health care…”
Get full text

Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer by Phillips, Gregory S, Freret, Morgan E, Friedman, Danielle Novetsky, Trelles, Sabrina, Kukoyi, Oluwaseun, Freites-Martinez, Azael, Unger, Robin H, Disa, Joseph J, Wexler, Leonard H, Tinkle, Christopher L, Mechalakos, James G, Dusza, Stephen W, Beal, Kathryn, Wolden, Suzanne L, Lacouture, Mario E

“…Persistent radiation-induced alopecia (pRIA) and its management have not been systematically described. To characterize pRIA in patients with primary central…”
Get more information

The Fugates of Troublesome Creek by Phillips, Gregory S, Vatanchi, Marjon, Glick, Sharon A

Get more information

Dermatologic infections in cancer patients treated with checkpoint inhibitors by Do, Mytrang H., Barrios, Dulce M., Phillips, Gregory S., Postow, Michael A., Warner, Allison Betof, Rosenberg, Jonathan E., Noor, Sarah J., Markova, Alina, Lacouture, Mario E.

“…The incidence of dermatologic infections in patients receiving checkpoint inhibitors (CPIs) has not been systematically described. Identify the incidence of…”
Get full text

Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features by Phillips, Gregory S., Mengden‐Koon, Stephanie, Dhossche, Julie, LeBoit, Philip E., Goldstein, Alisa M., Lee, Ina, Raffeld, Mark, Papanicolau‐Sengos, Antonios, Sargen, Michael R., Chung, Jina

“…A host of signature genetic alterations have been demonstrated in Spitz neoplasms, most notably fusions of kinase genes (including BRAF, ALK, ROS1, NTRK1,…”
Get full text

CME Part I: Immune checkpoint inhibitors to treat cutaneous malignancies by Barrios, Dulce M., Do, Mytrang H., Phillips, Gregory S., Postow, Michael A., Akaike, Tomoko, Nghiem, Paul, Lacouture, Mario E.

“…As the incidence of cutaneous malignancies continues to rise and their treatment with immunotherapy expands, dermatologists and their patients are more likely…”
Get full text

Persistent radiation-induced alopecia in patients with central nervous system tumors and head and neck sarcomas by Phillips, Gregory S., Friedman, Danielle Novetsky, Trelles, Sabrina, Kukoyi, Oluwaseun, Freret, Morgan, Freites Martinez, Azael David, Unger, Robin H., Disa, Joseph J., Wexler, Leonard H., Beal, Kathryn, Wolden, Suzanne L., Lacouture, Mario E.

“…Abstract only e23072 Background: Persistent radiation-induced alopecia (pRIA), or incomplete hair regrowth 6 months following radiotherapy (RT) completion,…”
Get full text